An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 1, 2011, Pages 59-66

  Kwiatek, M A ^a   Roman, S ^a   Fareeduddin, A ^a   Pandolfino, J E ^a   Kahrilas, P J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAVISCON;

ADULT; ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; EX VIVO STUDY; FEMALE; FLUOROSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IN VIVO STUDY; LIPID DIET; LOWER ESOPHAGUS SPHINCTER; MALE; MANOMETRY; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH PH; STOMACH PRESSURE;

ADULT; ALGINATES; ALUMINUM HYDROXIDE; ANTACIDS; DRUG COMBINATIONS; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MANOMETRY; MIDDLE AGED; SILICIC ACID; SODIUM BICARBONATE; TREATMENT OUTCOME;

EID: 79958108067     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04678.x     Document Type: Article

References (25)

1. Fletcher J, Wirz A, Young J, Vallance R, McColl KE,. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121: 775-83. (Pubitemid 32959387)
2. Pandolfino JE, Zhang Q, Ghosh SK, Post J, Kwiatek M, Kahrilas PJ,. Acidity surrounding the squamocolumnar junction in GERD patients: "acid pocket" versus "acid film". Am J Gastroenterol 2007; 102: 2633-41. (Pubitemid 350179327)
3. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE,. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010; 59: 441-51.
4. Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ,. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc 2010; 72: 272-8.
5. Ghosh SK, Kahrilas PJ, Brasseur JG,. Liquid in the gastroesophageal segment promotes reflux, but compliance does not: a mathematical modeling study. Am J Physiol Gastrointest Liver Physiol 2008; 295: G920-33.
6. Mandel KG, Daggy BP, Brodie DA, Jacoby HI,. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000; 14: 669-90. (Pubitemid 30352733)
7. Sandmark S,. Hiatal incompetence and studies on mechanics and principles of examination for hiatus hernia and gastro-oesophageal reflux: light contrast media. Acta Radiol Suppl 1963; 219: 28.
8. Moss HA, Washington N, Greaves JL, Wilson C,. Anti-reflux agents. Stratification of or flotation? Eur J Gastroenterol Hepatol 1990; 2: 45-51.
9. Washington N, Greaves JL, Wilson CG,. Effect of time of dosing relative to a meal on the raft formation of an anti-reflux agent. J Pharm Pharmacol 1990; 42: 50-3. (Pubitemid 20124197)
10. Hampson FC, Jolliffe IG, Bakhtyari A, et al. Alginate-antacid combinations: raft formation and gastric retention studies. Drug Dev Ind Pharm 2010; 36: 614-23.
11. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 1030-8.
12. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 2010; 59: 714-21.
13. Pandolfino JE, Ghosh SK, Zhang Q, Jarosz A, Shah N, Kahrilas PJ,. Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1033-40.
14. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 52-7. (Pubitemid 32104807)
15. Clarke AT, Wirz AA, Seenan JP, Manning JJ, Gillen D, McColl KE,. Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic. Gut 2009; 58: 904-9.
16. Clarke AT, Wirz AA, Manning JJ, Ballantyne SA, Alcorn DJ, McColl KE,. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket. Gut 2008; 57: 292-7. (Pubitemid 351288092)
17. Del Buono R, Wenzl TG, Ball G, Keady S, Thomson M,. Effect of Gaviscon infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH. Arch Dis Child 2005; 90: 460-3. (Pubitemid 40627439)
18. Tytgat GN, Simoneau G,. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension. Aliment Pharmacol Ther 2006; 23: 759-65. (Pubitemid 43344595)
19. Buts JP, Barudi C, Otte JB,. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146: 156-8. (Pubitemid 17019798)
20. Castell DO, Dalton CB, Becker D, Sinclair J, Castell JA,. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid. Dig Dis Sci 1992; 37: 589-93.
21. Washington N, Greaves JL, Iftikhar SY,. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension. Aliment Pharmacol Ther 1992; 6: 579-88.
22. Washington N, Steele RJ, Jackson SJ, Washington C, Bush D,. Patterns of food and acid reflux in patients with low-grade oesophagitis-the role of an anti-reflux agent. Aliment Pharmacol Ther 1998; 12: 53-8. (Pubitemid 28057405)
23. Dettmar PW, Hampson FC, Taubel J, et al. The suppression of gastro-oesophageal reflux by alginates. Int J Clin Pract 2007; 61: 1654-62. (Pubitemid 47404395)
24. Corvaglia L, Aceti A, Mariani E, De Giorgi M, Capretti MG, Faldella G,. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants. Aliment Pharmacol Ther 2011; 33: 466-70.
25. Chatfield S,. A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease. Curr Med Res Opin 1999; 15: 152-9. (Pubitemid 29481472)